Skip to main content
Clinical Trials/NCT00713063
NCT00713063
Completed
Phase 2

Behavioral Exercise Intervention for Smoking Cessation

Butler Hospital0 sites61 target enrollmentApril 2006

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Nicotine Dependence
Sponsor
Butler Hospital
Enrollment
61
Primary Endpoint
Self-reported smoking abstinence via Timeline Followback (TLFB)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to test the effect of a moderate-intensity aerobic exercise intervention for smokers interested in quitting smoking. We expect that this project will contribute much needed knowledge about the role of aerobic exercise in smoking cessation. If the efficacy of moderate-intensity, aerobic exercise for smoking can be established, smokers may have a valuable adjunct to more traditional smoking cessation approaches.

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
March 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • are between 18 and 65 years of age
  • are current smokers (i.e., smoking at least 10 cigarettes per day)
  • are sedentary, i.e., have not participated regularly in aerobic physical exercise (for at least 20 minutes per day, 3 days per week) for the past six months.

Exclusion Criteria

  • current DSM-IV Axis I psychiatric disorder as assessed by SCID-NP
  • Substance abuse or dependence (excluding nicotine dependence) within the past 6 months
  • lifetime DSM-IV diagnosis of a bipolar disorder as assessed by the SCID-NP
  • lifetime history of a psychotic disorder or current psychotic symptoms as assessed by the SCID-NP
  • current suicidality or homicidality
  • marked organic impairment
  • physical disabilities or medical problems (such as a history of diabetes, hypertension, seizure disorder, coronary heart disease, valvular heart disease, and pulmonary disease) or use of medications (such as beta blockers) that would prevent or hinder participation in a program of moderate intensity exercise
  • current pregnancy of intent to become pregnant during the next 12 weeks, and i) current use of any pharmacotherapy, including transdermal nicotine replacement, for smoking cessation

Outcomes

Primary Outcomes

Self-reported smoking abstinence via Timeline Followback (TLFB)

Time Frame: 12-months

Biochemically verified smoking abstinence via carbon monoxide and saliva cotinine

Time Frame: 12 Months

Similar Trials